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Abstract Different modalities of assisted ventilation improve breathlessness and exercise tolerance in patients with
chronicobstructivepulmonarydisease (COPD).Theaimofthis studywasto evaluatetheeffectsofthe additionof assisted
ventilationduringexercisetrainingonthe outcomeof a structuredpulmonaryrehabilitationprogramme (PRP) in COPD
patients.Thirty-threemale patientswith stable COPD (mean (SD) forced expiratory volume in1s (FEV1) 44 (16) % pred),
without chronic ventilatory failure, undergoing a 6-week multidisciplinary outpatient PRP including exercise training,
wererandomisedtotrainingduringeithermaskproportional assist ventilation (PAV:18 patients) or spontaneousbreath-
ing (SB: 15 patients). Assessment included exercise tolerance, dyspnoea, leg fatigue, and health-related quality of life
(HRQL).Five outof18 patients (28%) in the PAV group dropped outdue to lackof compliancewith the equipment.Both
groups showed significantpost-PRP improvementsin exercise tolerance (peakworkrate difference: 20 (95% CI 2.4--37.6)
and14 (3.8% CI to 24.2)W in PAVand SB group, respectively), dyspnoea and leg fatigue, but not in HRQL, without any
significant difference between groups. It is concluded that with the modality and in the patients assessed in this study,
assisted ventilation during training sessions included in a multidisciplinary PRP, was not well tolerated by all patients and
gaveno additionalphysiologicalbenefit in comparisonwith exercise trainingalone.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1287, available online athttp://www.idealibrary.comon
Keywords proportional-assist ventilation; non-invasive ventilation; exercise training; respiratorymuscles; dyspnoea.INTRODUCTION
Breathlessness is the most common symptom that
limits exercise in patients with chronic obstructive
pulmonary disease (COPD). Exercise training as part
of a pulmonary rehabilitation programme (PRP) can
improve exercise tolerance, dyspnoea and health sta-
tus in these patients (1,2). Intensity of exercise training
is of key importance. No increases in maximal exer-
cise capacity were observed in COPD patients follow-
ing low-intensity exercise training, whereas high-
intensity training improved both maximal and sub-
maximal exercise tests and induced both cardio-re-
spiratory and peripheral muscle adaptations (3,4).
Nevertheless, in these patients ventilatory limitation
may prevent patients from higher levels of intensity
of training.Received and accepted in revised form 20 December 2001.
Correspondence should be addressed to:Dr.Nicolino Ambrosino,
Fondazione S.Maugeri IRCCS,Divisione di Pneumologia Riabilitativa,
Istituto Scienti¢co di Gussago,Via Pinidolo 23,1-25064 Gussago (BS),
Italy.Fax: +39 030 2521718; E-mail: nambrosino@fsm.itThere is laboratory evidence that continuous positive
airwaypressure (CPAP) (5^7) andpressure supportven-
tilation (PSV) (8^10)may improvebreathlessness and ex-
ercise tolerance in these patients. Also, proportional
assist ventilation (PAV), a new mode of partial ventila-
tory assistance with characteristics of proportionality
and adaptability to the intensity and timing of patient’s
spontaneous ventilatory pattern, has been proven to be
e¡ective in improving exercise tolerance in severe, stable
COPD patients (11,12).The role of assisted ventilation in
PRP, if any, is still to be de¢ned. Recently, Hawkins et al.
(13) randomised severe COPD patients (mean FEV1: 29%
predicted), to 6-week exercise training with no ventila-
tory assistance or exercisewithmask PAV.These authors
showed that post-training iso-workrate minute ventila-
tion and arterialised venous blood lactate were reduced
only in the PAV group indicating a physiological training
e¡ect.We wondered whether PAVmight be a valuable
aid to PRP also in less severe COPD patients.Therefore,
this study was undertaken to test the hypothesis that
the addition of PAV during high-intensity exercise train-
ing, as part of a multidisciplinary PRP in patients with
mild stable COPDwas feasible andwould lead to greater
TABLE 1. Anthropometric, demographic, physiologic
and clinical characteristics of population in study*
PAV
(n= 18)
SB
(n= 15)
Age (years) (range) 64 (61^67) 65 (61^69)
Weight (Kg) 7878 73710
Height (cm) 17175 17177
BMI (kgcm2) 26.8718.7 24.872.9
FEV1 (l) 1.4370.57 1.1870.39
FEV1 (% predicted) 47.7718.7 40.1712.3
FVC (% predicted) 77.3715.2 74.2719.4
FEV1/VC 0.4170.17 0..3470.07
TLC (% predicted) 114.7721.4 119.7718.9
RV (% predicted) 161.0769.2 181.1748.8
MIP (cmH2O) 82.9725.8 72.4723.4
MEP (cmH2O) 147.9726.8 139.2725.1
PaO2 (kPa) 10.071.1 10.071.1
PaCO2 (kPa) 5.270.6 5.270.5
BDI 6.270.8 6.370.9
SGRQ total score (%) 40.6713.2 34..5715.8
BMI = Bodymass index; FEV1 = forced expiratory vo-
lume in1s; FVC = forced expiratory volume;TLC = total
lung capacity;RV = residual volume;MIP,MEP = maximal
inspiratory and expiratory pressures; PaO2, PaCO2 = ar-
terial oxygen and carbon dioxide tensions;BDI = baseline
dyspnoea index; SGRQ = St.George respiratory ques-
tionnaire.
*Values are shown asmean7SD
360 RESPIRATORYMEDICINEimprovements in exercise tolerance, dyspnoea and
health status than training alone.Our primary outcome
measures were exercise capacity and cardio-respiratory
response to exercise, dyspnoea and leg fatigue whilst
secondary outcome measure was health-related quality
of life (HRQL).
METHODS
Patients gave their informed consent to participate in
the study whichwas approvedby the Ethical Committee
of S. Maugeri Foundation and was conducted according
to the declaration of Helsinki.
Patients
The study was performed on consecutive male COPD
patients, without chronic respiratory failure, admitted
to an outpatient PRP from January 1998 to April 2000.
Diagnosis of COPD was made according to the Ameri-
canThoracic Society (ATS) guidelines (14). Patients had a
historyof smoking (420 pack-year) but they were all ex-
smokers. At the timewhen they were recruited for this
study, all patients were in stable conditions without any
exacerbations in the previous 4 weeks. Patients with
chronic respiratory failure, other organ failure, cancer
or inability to cooperate were excluded from the study.
Arterial exercise-induced hypertension (4200mmHg
systolic and130mmHg dyastolic), was also a criterion of
exclusion from the study.
All patients received regular treatment with inhaled
bronchodilators and no patient received regular treat-
ment with inhaled or oral steroids except during the ex-
acerbations of their diseases. No change in the routine
therapy was made in the month preceding the inclusion
in the study. None of the patients were on long-term
oxygen therapy or on long-term homemechanical venti-
lation.
Demographic, anthropometric, clinical and functional
characteristics of patients are shown inTable1.
Measurements
The following baseline assessments weremade:
Lung and respiratorymuscle function: Lung volumes and
forced vital capacity (FVC)weremeasuredbymeans of a
constant volumebodyplethysmograph (Medical Graphic
Corp, St. Paul,MN,U.S.A.).The predicted values accord-
ing to Quanjer were used (15). Maximal inspiratory and
expiratory pressures (MIP and MEP, respectively) were
measured at the level of functional residual capacity
(FRC) and total lung capacity (TLC), respectively (16),
using a respiratory module system (Medical Graphic
Corp, St. Paul, MN,U.S.A.). Arterial blood was sampled
at the radial artery while the patients in the sitting posi-tion were breathing room air for at least 1h. PaO2,
PaCO2 and pH were measured by means of an auto-
mated analyser (Ciba-Corning 840, Med¢eld, MA,
U.S.A.).
Outcomemeasures
Exercise tolerance: Symptom-limited incremental exercise
testswereperformedon anelectricallybrakedcycloerg-
ometer (Ergometrics 800S, Sensormedics, Yorba Linda,
CA, U.S.A.) using the standard incremental cycle exer-
cise protocol increasing the load by 10W min1. Mixed
expired gas data, minute ventilation (V0E), and breathing
pattern, were continuously monitored as average values
of 20-s intervals atrest andduring exercisebymeans of a
computerised system (2900Z, Sensormedics,Yorba Lin-
da, CA, U.S.A.). Indirect estimation of lactate threshold
(LT) was computed using theV-slope method (17). Elec-
trocardiographic activity was monitored continuously
and systemic arterial blood pressure was registered
every 3min using a sphygmomanometer. At rest and at
1-min intervals, during exercise, patients were asked
about their perceived breathlessness and sensation of
leg discomfort by pointing to a number or phrase on a
PULMONARYREHABILITATIONINMILDCOPDPATIENTS 36110-point Borg scale set in large type on a sheet in front
of them (18).
Exercise performancewas also assessed by the 6-min
walking distance test (6 MWD) (19). Three practice at-
tempts were performed, the best of which was consid-
ered.
Oxygen saturation (SaO2) was continuously moni-
tored by pulse oximetry (Oxicap Monitor, Ohmeda,
Louisville,CO,U.S.A.) during both exercise tests.
Dyspnoea: Before the PRP, dyspnoeawas evaluated by
means of Italian translations of the Baseline Dyspnoea
Index (BDI) (20). BDI ranges from 0 to12, the lower the
rating the worst the dyspnoea. The Transitional Dys-
pnoea Index (TDI) (20) was used at the end of the PRP
to evaluate di¡erences in dyspnoeawithbaseline compo-
nents (range9, maximal worsening to +9, maximal im-
provement).
Health-related quality of life: HRQL was assessed by
means of the validated Italian Version of the St.George
Respiratory Questionnaire (SGRQ) (21,22). The SGRQ
consists of 76 items and measures three components:
symptoms, activity, impact. The three components of
SGRQ are scored separately in the range from 0 to
100%, 0 indicating no impairment, and a total score is
computed (21).
Pulmonary rehabilitation programme
Our PRP was a Day-Hospital-based outpatient multidis-
ciplinary 6-week PRP which has been described else-
where (23,24). A multidisciplinary team consisting of
chest physicians, nurses, physiotherapists, dietician and
psychologist o¡ered care. The programme included the
optimisation of the pharmacological treatment, three 3-
h sessions per week for 6weeks, including: (i) supervised
incremental exercise until achieving 30-min continuous
cycling at 50^70% of the maximal load achieved on the
incremental cycloergometer exercise test carried out at
admission.The criteria to increase or decrease intensity
and/orduration of training sessionsweregivenbyMaltais
et al. (25); (ii) abdominal, upper and lower limb muscle
activities lifting progressively increasing light weights
(300^500g), shoulder and full-arm circling and other ex-
ercises; (iii) patient and family education. If desired pa-
tients could rest in dedicated beds and havemeals at the
hospital facilities.
Protocol
After baseline assessments, the patients were rando-
mised into two groups: PAV group (18 patients) per-
formed exercise training sessions (23^25) with mask-
supportedventilation in PAVmode. Spontaneousbreath-
ing (SB) group (15 patients) performed exercise trainingwithout any breathing equipment.Themodality of train-
ing and thewhole PRPwas the same for the two groups.
Assisted ventilation was delivered through commer-
cial nasal (13 patients) or facial (5 patients) masks (Re-
spironics Inc., Murrysville, PA, U.S.A.) of adequate size,
according to the patient’s choice during a preliminary ac-
climatisation session. PAV was delivered by means of a
portable ventilator (BiPAPs Vision,Ventilatory Support
System,Respironics Inc.,Murrysville, PA,U.S.A.) capable
of compensating for leaks.This ventilator is a micropro-
cessor-controlled positive pressure ventilatory assist
system capable of operating in the CPAP, PSV and PAV
modes.The ventilator incorporates a user interfacewith
multifunction keys, real-time graphic displays, and inte-
gral patient and system alarms. The ventilator circuit
was equippedwith the SandersNRV-2 plateau valve (Re-
spironics Inc.) to prevent carbon dioxide rebreathing
(26).
Setting of PAV
The ventilator delivers PAV according to the motion
equation, generatingpressure inproportion to apatient’s
spontaneous e¡ort. A portion of the total mechanical
workload, i.e. elastance and resistance, is taken over ac-
cording to a level of assistance, which is decided by the
caregiver and can speci¢cally unload the resistive (£ow
assist: FA) and the elastic (volume assist: VA) burden.
During a preliminary session, with the patient on the cy-
cloergometer, PAV was set at rest according to the pa-
tient’s comfort as previously described (12). Brie£y, VA
and FA were set initially at the minimum value of 2 cm
H2Ol
1 and 1cm H2Ol
1.s, respectively, and then were
set separately. Leaving FA unchanged,VAwas increased
slowlyby steps of 2 cmH2Ol
1until thepatient indicated
that breathing was uncomfortable.Then, the level of as-
sistance was decreased by one step (2 cm H2Ol
1). This
levelwas considered as themaximum toleratedVA level.
To set FA, a stepwise approach similar to the one de-
scribed above was used, by keeping VA at 2 cm H2Ol
1
and slowly increasing FA by steps of 1cm H2Ol
1.s until
the patient felt uncomfortable with that level of assis-
tance. Then, the level of assistance was decreased by
one step (1cm H2Ol
1 s). This level was considered as
the maximum tolerated FA level. The ¢nal setting of
PAV corresponded to 80% of maximal tolerated indivi-
dual values of VA and FA. If needed, the settings of PAV
could be changed during the exercise.
An end-expiratory positive airway pressure (EPAP)
amounting to 2 cmH2O,was addedby ventilator default.
Statistical analysis
Di¡erences between PAV and SB group changes in re-
sponse to rehabilitation in peakworkload, cardiorespira-
TABLE 2. Baseline exercise tolerance*
362 RESPIRATORYMEDICINEtory parameters, 6MWD, dyspnoea, leg discomfort, to-
tal and component SGRQ scores were identi¢edby a re-
peated measures analysis of variance model with one
factor.The PROCGLMprogram from SAS (SAS Institute
Inc., Cary, NC,U.S.A.) was used for these analyses.The
analyses were conducted on the data set for all the ran-
domised patients (intention to treat analysis) as well as
on the data set for thepatientswho completed the study
only (per protocol analysis).
Fisher’s exact testwasused to evaluate the di¡erences
between drop-outs and patients who completed the
protocol.
All statistical tests were two sidedwith a type I error
(a) of 0.05.
RESULTS
Randomisation
Figure 1 shows the study design. In the study period 83
male COPD patients were screened; 50 patients were
not included in the study due to concomitant ischaemic
disease (10 patients), hypertension (31), other comorbid-
ities (5) and lack of consensus (4). Therefore 33 patients
entered the study, 18 and 15 patients being randomised
to PAVor SB, respectively.
Table1shows the baseline characteristics of all the pa-
tients enrolled in the study. No signi¢cant di¡erences
were observed between the two groups. The patients
had moderate-to-severe COPD (ATS stages I^III: 8, 4, 6
and 4, 4, 7 patients in PAV and SB group, respectively)
with hyperin£ation. All patients were normocapnic.
Baseline exercise tolerance is provided in Table 2.
There was no signi¢cant di¡erence between the two
groups. Exercise capacity of all enrolled patients was
moderately reduced. All patients interrupted incremen-
tal exercise test due to dyspnoea, whereas no patientScreening
(n=83)
Recruitment
(n=33)
Assessment
Randomisation
PAV
n=18
PAV
n=9
SB
n=15
SB
n=10
Pulmonary
rehabilitation program
18 training sessions
Reassessment
(n=19)
FIG. 1. Study design: PAV = proportional assist ventilation
group; SB = spontaneousbreathing group.due to leg fatigue. No patient showed exercise-induced
arterial desaturation. Mean number of training sessions
was 17.471.3 and 17.071.8 in PAV and SB group, respec-
tively. Among patients who completed the protocol, 6
out of 9 patients in PAV and 7 out of 10 patients in SB
group (P=0.95) had participated in another PRP 12^24
months before the admission to present study.
Drop-outs
Eight out of18 patients (44%) in the PAV group dropped
out.The causes of drop-outwere: lackof compliance due
to discomfort caused by the experimental setting (mask
and/or ventilatory setting) within the ¢rst 1^4 sessions
(median = 2): 5 patients (28% of patients randomised to
PAV); exacerbation of disease: 2 patients; systemic arter-
ial bloodhypertension during exercise training:1patient.
One more patient su¡ered from unexpected coronary
heart disease during the ¢nal exercise testing and was
therefore excluded from the ¢nal analysis. In SB group 5
outof15 patients (33%) droppedoutdue to acute exacer-
bation of COPD (2 cases), systemic hypertension during
exercise training (2) and unexpected coronary disease
(1). No patient in SB group dropped out due to lack of
compliance to the exercise sessions. At the end of the
PRP, complete data setswere therefore obtained in 9pa-
tients of the PAV group and in 10 of the SB group.
Although there was no di¡erence in the overall rate of
drop-outs between PAV and SB group (Fisher P=0.47),
the di¡erence in drop-outs due to lack of compliance (5
vs 0 in PAV and SB, respectively) was clearly signi¢cant
(P=0.03). Drop-outs of either group did not di¡er from
patients who completed the programme in any baselinePAV
n= 18
SB
n = 15
Peakworkrate, (W) 87.8725.3 80.7724.6
Peak fC, (breathesmin1) 123.8714.7 118.1715.2
PeakV

O2 (lmin
1) 1.2470.37 1.1770.31
PeakV

O2, %predicted 62.0715.4 61.0713.2
PeakV

O2 kg
1
(mlmin1kg1)
15.874.1 15.974.3
PeakV

O2kg,
%predicted
52711.6 55714.8
PeakV

E(lmin1) 39.9710.6 37.1711.1
V

O2, LT, (lmin
1) 0.8270.23 0.7870.14
V

O2 kg
1
LT (mlmin
1kg1) 10.172.8 10.67 2.2
6MWD(m) 490774 439777
*Values are shown asmean7SD.
fC = cardiac frequency; V

O2 = oxygen uptake; V

E =
MinuteVentilation; LT = Lactate threshold; 6MWD = 6-
minwalkingdistance test.
PULMONARYREHABILITATIONINMILDCOPDPATIENTS 363characteristic.Drop-outs of the two groupsweregener-
ally similar.
Ventilatory settings
On average,1173minwere spentby thephysiotherapist
to set the ventilator. MeanVA and FA applied during all
training sessions were 6.672.2 cm H2O.l
1 and
3.571.6 cm H2O.l
1s, respectively. In the ¢rst training
sessions, there was the need to adjust the level of assis-
tance in 12 out of 18 patients of PAV group. Air leaks,
monitored by means of the display of the ventilator, did
not occur even in patients wearing the nose mask. The
level of EPAP was never modi¢ed during training ses-
sions.
Lung and respiratorymuscle function
No statistically signi¢cant di¡erence was observed in
either group in lung or respiratory muscle function as a
consequence of the PRP.
Exercise tolerance
Themean training intensity achieved during each session
is represented in Fig. 2. Intensity of training increased
progressively in both groups from sessions1to 7 and pla-
teaued after the 8th session at approximately 70^80% of
the baseline peak workload. Five out of 9 patients (55%)
in the PAV group and 5 out of10 patients (50%) in the SB
group were able to reach and sustain the target 80% of
the baseline peak workload during training. No signi¢-
cant di¡erence in the maximal training intensity and in
the number of sessions spent to attain it was observed
between the two groups.40
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FIG. 2. Group mean values (7SD) for training intensity sus-
tained during the training sessions. The training intensity is ex-
pressed in percent of peak workrate reached at the baseline
exercise test (%peakworkrate) in the PAV group (¢lled squares
and solid line) and inthe SB group (circles and dashed line).There was no signi¢cant di¡erence, between the two
groups, in the post-PRP changes in exercise tolerance
and in the cardio-respiratory response (Table 3). Figure
3 shows the individual changes in peak workload and
6MWD determined by the PRP in both groups. After
the PRP, the peak workrate increased on average from
87.8727.7 to 107.8736.0W (P=0.03) in PAV and from
87..0721.6 to 101.0725.6W in SB group (P=0.013). Post-
PRP changes in 6MWD were: from 488780 to
504783m (P=0.30) and from 456780 to 503783m
(P=0.002) in PAVand SB group, respectively.
Five outof 9 (55%) in PAVand 4 outof10 patients (40%)
in SB group showed a post-PRP increase in peak work-
load by more than 15% (Fisher P=0.65) (improvers),
whereas 2 out of 9 (22%) in the PAV and 5 out of 10
(50%) in the SB group (Fisher P=0.35), were able to in-
crease the post-PRP 6MWDbymore than 54m, anesti-
mated threshold of clinical importance (improvers) (18).
No signi¢cant di¡erences in baseline characteristics
were observedbetween improvers and non-improvers.
Dyspnoea, leg discomfort and health status
Table 4 shows the changes in dyspnoea and leg discom-
fort as assessed byTDI and Borg score at iso-load. The
TDI improved signi¢cantly inbothgroups. Subjective rat-
ing of dyspnoea and leg discomfort at the same exercise
workload signi¢cantly improved in both groups, without
any signi¢cant di¡erence between groups.
Mean changes in SGRQ are shown inTable 5.Mean to-
tal and component SGRQ scores did not change after
PRP in either group.Two out of 9 (22%) patients in PAV
and 4 out of10 (40%) patients in SB group (Fisher P=0.63)
improved their SGRQ total score bymore than 4 points
which is considered to be clinically relevant (20).
Analysis according to intention to treat (ITT) revealed
no di¡erent results when compared to analysis per pro-
tocol.
DISCUSSION
This study investigated the routine feasibility and the
clinical and physiological e¡ects of the addition of as-
sisted ventilation to exercise training sessions as part of
amultidisciplinary PRP in patientswith stable COPD.We
found no additional bene¢t of mask PAVon exercise tol-
erance, dyspnoea, leg fatigue and health status when
compared to training alone. Furthermore, the high rate
of lack of compliance and the need of time spent by phy-
siotherapists to set the ventilator and to supervise the
training session during assisted ventilation were practi-
cal drawbacks of the addition of mask PAVduring a high-
intensity training programme, at least in the routine set-
ting and in the patients of this study.
TABLE 3. Meanchanges in cardiorespiratoryparameters and 6 MWDafter18 training sessions in both groups
PAV
n= 9
SB
n= 10
Mean (95% CI) di¡erence in changesbetweengroups P value
DPeakworkrate (W) 20.0 14.0 6 (12.3 to 24.3) 0.49
D6MWD (m) 15.8 47.0 31.2 (68.3 to 5.8) 0.09
DIsoworkrate fC 6.5 4.6 1.95 (10.35 to 6.45) 0.63
DBaselineV

E, l*min-1 1.1 1.8 2.9 (8.1to 2.3) 0.25
DPeakV

E (lmin1) 10.5 7.15 3.35 (11.6 to18.3) 0.64
DV

E, isoworkrate (lmin1) 2.1 2.48 0.375 (3.25 to 4) 0.83
DrestV

O2, (lmin
1) 0.03 0.05 0.08 (024 to 0.08) 0.30
DrestV

O2kg
1(mlmin1kg1) 0.34 1.14 1.48 (3.9 to 0.9) 0.21
D PeakV

O2, (lmin
1) 0.27 0.27 0 (0.45 to 0.45) 0.99
D PeakV

O2 kg
1(mlmin1kg1) 3.33 5.13 1.8 (8.1to 4.5) 0.55
DV

O2, LT(lmin
1) 0.33 0.11 0.22 (0.13 to 0.57) 0.18
DV

O2 kg
1
LT (mlmin
1kg1) 3.7 2.47 1.23 (4.6 to 7.07) 0.86
P values and 95% con¢dence intervals representdi¡erencesbetweengroups.
6 MWD = 6-minwalking distance; fC = cardiac frequency; V

O2 = oxygen uptake; V

O2 kg
1 = oxygen uptake Kg1; V

E =
minute ventilation;LT = lactate threshold.
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FIG. 3. Individual changes inpeakworkrate (upper panel) and 6MWD (lower panel) in the PAVand inthe SBgroup.
364 RESPIRATORYMEDICINEOthers have found thatdomiciliarymask PSV adminis-
tered nightly could be used successfully to enhance the
e¡ects of rehabilitation in severe COPD patients, even
in non-hypercapnic patients (27). Another study sug-
gested that improvements in 6MWD can occur afterlong-term ventilation in patients with chronic hypercap-
nia [28]. Previous physiological studies have shown that
CPAP (5^7), PSV (8^10) and PAV (11,12,29) may improve
exercise tolerance andbreathlessness in COPD patients.
Respiratory muscle unloading and reduction in intrinsic
TABLE 4. Mean changes in dyspnoea and legdiscomfort after18 training sessions in both groups
PAV
n =9
SB
n = 10
Mean (95% CI) di¡erence in changesbetweengroups P value
Iso-load Borg D score 3.56 3.3 0.25 (2.26^1.76) 0.80
Iso-load Borg F score 1.88 1.5 0.38 (3.35^2.59) 0.78
TDI (total) 5.3 5.2 0.1 (2.4^2.6) 0.63
P values and 95% CIrepresentdi¡erencesbetween groups.
D = dyspnoea;F = leg fatigue/discomfort;TDI = transitional dyspnoea index.
TABLE 5. Meanchangesintotal andcomponent S.Georgerespiratoryquestionnaire (SGRQ) scores after18 training sessionsin
both groups
PAV
n= 9
SB
n= 10
Mean (95% CI) di¡erence in changesbetween groups P value
SGRQ (total) 0.6 3.4 2.8 (2.5^8.1) 0.28
SGRQ (symptoms) 4.1 0.7 3.4 (11.8^18.7) 0.64
SGRQ (activity) 5 2.3 7.3 (1.5^16.1) 0.09
SGRQ (impact) 5.2 5.3 0.1 (7.8^8.1) 0.97
P values and 95% CIrepresentdi¡erencesbetween groups
PULMONARYREHABILITATIONINMILDCOPDPATIENTS 365positive end-expiratory pressure (PEEPi) have been con-
sidered among theunderlyingmechanisms (5^7,10). It has
also been suggested that PSV prolongs exercise-induced
lactataemia in these patients (30).Despite the promising
results of these physiological studies and di¡erent from
our hypothesis, wewereunable to show, in a routine set-
ting, any substantial bene¢t in adding PAV to awell-struc-
tured PRP including exercise training (23,24).Whatmight
be the reasons for the observed lack of additional bene-
¢t?
Sample size
We arewell aware that the small sample sizemight have
in£uenced the lack of statistical di¡erences between the
two interventions and we cannot exclude the risk of a
beta error. Nevertheless, our results showed the com-
plete absence of any trends for a di¡erence. Further-
more an unlikely small statistically, if not clinically,
signi¢cant di¡erence between groups (if any) would not
be aworthwhile reason to increase the costs of the PRP
(e.g. due to ventilators and other equipments, and time
spent by physiotherapists to set the ventilator, to check
possible leaks, to reset the ventilator when needed), and
to submitpatients to anunpleasantequipment (e.g.mask
and related troubles), with a substantial risk of patients’
lackof compliance as it happened in this study.Therefore,
we are con¢dent that the substantial ‘negative’ message
of our study is not weakened by the low power of the
study.Severity of disease
In this study, we treated stable moderate-to-severe
COPD patients without chronic hypercapnia. Recently,
Hawkins et al. (13) randomised 12 COPD patients, more
severe than ours (FEV1: 29% predicted), to 6-week exer-
cise training with no ventilatory assistance or exercise
withmask PAV.Di¡erent from our study, these prelimin-
ary results showed that post-training iso-workrate min-
ute ventilation and arterialised venous blood lactate
were reduced only in the PAV group indicating a physio-
logical training e¡ect. Although all patients of our study
interrupted the incremental exercise test due to dys-
pnoea and not to leg fatigue, and therefore, they could
be considered as appropriate candidates to get bene¢ts
from assisted ventilation during exercise, the overall les-
ser severity of the patients of our study might account
for di¡erences. Indeed, in our study, di¡erences in post-
PRP changes in peak workrate between treatment
groups were more relevant in more severe patients
(ATS stage III:DW17: vs 5 in PAV and SB group, respec-
tively) than in ATS stage I and II patients (DW22: vs 20).
Furthermore, the increase in exercise tolerance ob-
servedwith PAV in our previous study (12), was obtained
in COPD patients with chronic ventilatory failure.
E¡ectiveness of themultidisciplinary PRP
The lack of di¡erencesmight be due to the fact that our
outpatient PRP was so e¡ective that a further improve-
ment was di⁄cult to reach, at least in these stable
366 RESPIRATORYMEDICINEnon-hypercapnic patients. Indeed, our PRP did not con-
sist onlyof cycle training sessionsbut also included amul-
tidisciplinary intervention with abdominal, upper and
lower limb muscle activities, education sessions (24).
These other components might have contributed to en-
hance the bene¢t of the PRP also in the SB group thus
potentially hiding additional bene¢ts of PAV (if any).
A discrepancy between the results of previous physio-
logical studies of exercise and application to rehabilita-
tion has also been observed with other therapeutical
tools. For instance, despite the fact that supplemental
oxygen in patients with COPD and exercise hypoxaemia
results in acute improvements in exercise tolerance and
dyspnoea, no additional bene¢t in providing supplemen-
tal oxygen during a training programme was found by
Garrod et al. (31).
The lack of changes in lung function after the PRP in
either group is not surprising and is consistent with pre-
vious reports (2,24).The lackof changes inMIP is not sur-
prising as our PRP did not include any speci¢c
respiratorymuscle training (24).
Modality of ventilation
Among di¡erentmodalities of ventilation, we chose PAV
on the basis of the successful previous physiologic study
in hypercapnic stable COPD patients (12) and of the
study by Dolmage and Goldstein (11). Due to its claimed
characteristics, i.e. proportionality and adaptability to
the intensity and timing of spontaneous ventilatory pat-
tern, PAV should be of particular value to support exer-
cise. Nevertheless, a potential complication of PAV is
that its appropriate setting requires measurement of
the patient’s respiratory mechanics. In a study in resting
stable, chronically hypercapnic COPD patients (32),
mask PAV, set at patient’s comfort like in this study, was
able to unload about 70% of the total elastic load of the
respiratory system but only 26% of the resistive burden.
In this study, PAV was set according to patient’s comfort
at rest without any measurement of respiratory me-
chanics which otherwise would be impossible in a rou-
tine setting. It is quite possible that, with the increased
ventilatorydemands of exercise, the degree of assistance
may be inadequate during exercise and this may explain
the poor compliance and lack of e¡ect. Nevertheless in
the previous study (12), we did not need to modify PAV
setting during exercise. Moreover, adjusting ventilator
setting continuously during exercise greatly increases
the degree of complexity of sta⁄ng involvement and
therefore costs. Therefore, we cannot exclude the fact
that at least in some cases ventilator setting has not
matched the patient’s physiological characteristics.
Due to the lack of measurement of the patient’s re-
spiratory mechanics, another possible problem might
be the inappropriate setting of EPAP. It has been sug-gested to avoid setting EPAP above the level of PEEPi
since this may determine a signi¢cant rise in end-expira-
tory lung volume and, therefore, a greater hyperin£a-
tion. Although in our study EPAP was set by default of
the ventilator at 2 cm H2O, a value corresponding to
the PEEPi levels reported in resting stable COPD (33), it
should be considered that patients’ respiratory me-
chanics can change during exercise, for example due to
an increase in PEEPi (7).
Protocol
Patients and investigators were unblinded during the
study. A sham ventilation (for example 2 cm H2O CPAP
by default of ventilator) would be a method to blind pa-
tients.Nevertheless this would result in loading respira-
torymuscles of the control group.Furthermore thebias,
if any, would favour the study group which actually did
not happen.
In conclusion, stable moderate-to-severe COPD pa-
tients without chronic ventilatory failure, do not bene¢t
from the addition of assisted ventilation (in PAV modal-
ity) to training sessions; for these patients a multidisci-
plinary PRP including high-intensity training may be
su⁄cient to achieve improvements in exercise tolerance
and dyspnoea.Whether PAV or other modalities of as-
sisted ventilation may be a useful adjunct to pulmonary
rehabilitation programmes for patients with more se-
vere disease, namely those with chronic ventilatory in-
su⁄ciency, remains to be elucidated by further
prospective, randomised controlled studies.
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